PT-141 (Bremelanotide) 10 mg – Driada Medical EU

PT-141 (Bremelanotide) by Driada Medical EU is a revolutionary peptide treatment designed to address sexual dysfunction and low libido in both men and women. Unlike traditional ED medications that act on the vascular system, PT-141 works directly on the nervous system to increase sexual desire and physiological arousal.

Product Specifications

Mechanism of Action: The "Brain" Approach

PT-141 is unique in the world of sexual health. While drugs like Viagra (sildenafil) or Cialis work by increasing blood flow (vascular), PT-141 acts on the central nervous system.

• Melanocortin Receptors: It targets specific melanocortin receptors in the brain (hypothalamus) that regulate mood and sexual behavior.

• Desire vs. Function: By stimulating these receptors, it helps bridge the gap between mental desire and physical arousal, making it effective even when vascular treatments fail.

Key Benefits for Men and Women

Bremelanotide is one of the few aphrodisiacs effective for both sexes, treating the root cause of low libido.

1. Increased Libido (Desire)

For individuals suffering from Hypoactive Sexual Desire Disorder (HSDD), PT-141 can restore the natural urge for sexual intimacy. It is widely considered the most effective peptide for boosting "drive."

2. Enhanced Performance (ED)

For men, it supports stronger erectile quality. Because it works through the nervous system rather than just blood pressure, it can be effective for men who do not respond well to standard PDE5 inhibitors.

3. Rapid Onset

It is a fast-acting peptide. Users typically experience effects within a few hours of administration, allowing for planned intimacy without daily dosing.

Usage, Dosage, and Administration

Note: PT-141 is administered via subcutaneous injection (typically in the abdominal fat) using the provided sterile water for reconstitution.

• Timing: Administer approximately 45 minutes to 2 hours before anticipated sexual activity.

• Dosage: Dosages vary individually. A common starting protocol is often low (e.g., 1–2 mg) to assess tolerance, as higher doses increase the risk of nausea.

• Frequency: It is not intended for daily use. Recommended use is generally limited to 2–3 times per week to avoid desensitization.

Side Effects and Safety Profile

PT-141 is effective but has a distinct side effect profile that users must manage.

• Common Side Effects:

  • Nausea: This is the most common complaint. It usually passes quickly or can be mitigated by taking an antihistamine or injecting after a light meal.

  • Flushing: Warmth or redness in the face/neck.

  • Headache: Mild headaches may occur.

• Contraindications (Who Should Avoid It):

  • Heart Conditions: PT-141 can temporarily raise blood pressure. It is unsafe for individuals with uncontrolled hypertension or cardiovascular disease.

  • Melanoma Risk: Patients with a history of melanoma or skin cancer should avoid melanocortin agonists.

  • Pregnancy: Not for use by pregnant or breastfeeding women.

Frequently Asked Questions (FAQ)

1. How is PT-141 different from Viagra or Cialis?

Viagra is a "plumbing" drug—it helps blood flow to the penis but does not create desire. PT-141 is a "brain" drug—it increases the sexual desire and arousal signals sent from the brain to the body.

2. Can women use PT-141?

Yes. It is one of the few FDA-approved treatments (under brand names like Vyleesi) specifically for premenopausal women with low sexual desire (HSDD).

3. Will it make me nauseous?

Nausea is a known side effect for some users. To minimize this, start with a lower dose for your first injection, or take it with a small amount of food.

4. How long do the effects last?

The window of effectiveness is quite long. While it takes about 1–2 hours to kick in, the effects on increased libido can last for 6 to 10 hours (and sometimes up to 24 hours) depending on the individual.